Bupropion-induced epileptic seizures;Crises d'épilepsie induites par le bupropion

Revue Neurologique

Volumn 160, Issue 6-7, 2004, Pages 701-703

  Kuate, C ^a   Gelisse P ^a   Baldy Moulinier, M ^a   Crespel, A ^a  

^a GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

Acute symptomatic seizure; Epilepsy; Zyban Bupropion

Indexed keywords

AMFEBUTAMONE; CODEINE;

ADULT; ARTICLE; CASE REPORT; FAMILY HISTORY; FEMALE; HUMAN; MALE; MYOCLONUS EPILEPSY; PHOTOSENSITIVITY; PRESCRIPTION; SEIZURE; SMOKING CESSATION; TENDON REFLEX; TONIC CLONIC SEIZURE;

EID: 3843125196     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0035-3787(04)71021-8     Document Type: Article

References (6)

1. BARBARA M, KEN B, JAMES MW. (2002). Drug safety without borders: concerns about bupropion. CMAJ, 16:447.
2. BARTSCH P. (2002). Bupropion et cessation tabagique. Rev Med Brux, 23: 185.
3. JORENBY DE, LEISCHOW SJ, NIDES MA et al. (1999). A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med, 340: 685-691.
4. THOMAS P, GENTON P, GELISSE P, WOLF P. (2002). Juvenile myoclonic epilepsy. In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, et Wolf P eds. Epileptic Syndromes in Infancy, Childhood and Adolescence (3rd edition). John Libbey & Co Ltd, pp. 335-355.
5. WOOLTORTON E. (2002). Bupropion (zyban, wellbutrin SR): Reports of deaths, seizures, and serum sickness. CMAJ, 166: 68.
6. ZOGUEREH DD, DELMONT J. (2000). Antimalarial drugs and their ways to use in the African milieu. Sante, 10: 425-433.